Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
01:29:59 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.6400 CAD | 0.00% |
|
+8.47% | -8.57% |
| 05/08 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| 05/08 | Grown Rogue International Inc., Q2 2026 Earnings Call, Aug 04, 2026 |
| Market Cap | 11Cr 9.95Cr 9.34Cr 8.51Cr 16Cr 1.1TCr 16Cr 109.7Cr 43Cr 548.86Cr 43Cr 42Cr 1.83TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 11Cr 9.64Cr 18Cr 1.24TCr 18Cr 124.33Cr 49Cr 622.05Cr 49Cr 48Cr 2.07TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 week | +8.47% | ||
| Current month | +10.34% | ||
| 1 month | -4.48% | ||
| 3 months | +30.61% | ||
| 6 months | +28.00% | ||
| Current year | -8.57% |
| 1 week | 0.6 |  | 0.65 |
| 1 month | 0.52 | | 0.67 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.22 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 10,00,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +8.47% | 0.00% | +178.26% | 11Cr | |
| -0.18% | -0.86% | -9.81% | -7.24% | 1.34TCr | |
| -0.55% | -2.89% | +3.42% | +2.05% | 501.29Cr | |
| -0.16% | -0.96% | -31.83% | -56.19% | 505.99Cr | |
| +1.91% | +4.01% | +6.21% | -29.83% | 415.71Cr | |
| +0.19% | -1.37% | -13.03% | -5.79% | 365.62Cr | |
| -0.75% | -4.65% | -6.68% | -0.32% | 344.27Cr | |
| +0.78% | -1.84% | -5.34% | +15.75% | 339.17Cr | |
| +0.82% | +2.17% | -12.38% | -15.03% | 248.17Cr | |
| -3.91% | -12.46% | -15.14% | +24.49% | 170.94Cr | |
| Average | -0.18% | -1.12% | -8.46% | +10.62% | 424.01Cr | |
| Weighted average by Cap. | -0.05% | -1.32% | -9.31% | -10.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.34Cr 2.2Cr 2Cr 3.76Cr 257.83Cr 3.83Cr 26Cr 10Cr 129.23Cr 10Cr 9.92Cr 430.84Cr | 3.24Cr 2.81Cr 2.64Cr 2.4Cr 4.52Cr 309.46Cr 4.59Cr 31Cr 12Cr 155.12Cr 12Cr 12Cr 517.13Cr |
| Net income | -1.13Cr -98.02L -92.02L -83.8L -1.57Cr -107.87Cr -1.6Cr -11Cr -4.22Cr -54Cr -4.24Cr -4.15Cr -180.26Cr | 17.3L 15L 14.08L 12.82L 24.09L 17Cr 24.5L 1.65Cr 64.61L 8.27Cr 64.94L 63.53L 28Cr |
| Net Debt | 37.04L 32.12L 30.15L 27.46L 51.6L 35Cr 52.46L 3.54Cr 1.38Cr 18Cr 1.39Cr 1.36Cr 59Cr | 1.53Cr 1.33Cr 1.25Cr 1.13Cr 2.13Cr 146Cr 2.17Cr 15Cr 5.71Cr 73Cr 5.74Cr 5.62Cr 243.98Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | CA$0.6400 | 0.00% | 15,800 |
| 12/26/12 | CA$0.6400 | +1.59% | 11,000 |
| 11/26/11 | CA$0.6300 | +1.61% | 9,500 |
| 10/26/10 | CA$0.6200 | +3.33% | 34,500 |
| 07/26/07 | CA$0.6000 | -1.64% | 2,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
